Virtual Event — Prescriptions for Change

The Price of Drugs and State Cost Control Strategies

2 Min Read

Sep 17, 2020

By

Kari M. Bruffett,

Peter F. H. Barstad,

Wyatt J. Beckman, M.P.H., C.H.E.S.
Chart showing state policy levers in the retail prescription drug supply chain

Key Points

    • State legislatures across the country have passed 164 laws in the past two years specifically targeting prescription drug pricing, payment or costs.
    • In 2020, six such bills were introduced in the Kansas Legislature, focused on regulating pharmacy benefit managers (PBMs), limiting out-of-pocket costs for insulin, and creating a drug importation program. However, none of the bills were enacted into law.
    • While the federal government plays a lead role in approving drugs, protecting intellectual property and mandating discounts, states have an expanding set of policy levers they can access to control costs, including leveraging the purchasing power of state Medicaid programs.
    • While laws aimed at increasing transparency in prescription drug pricing have been gaining momentum, no state currently has laws requiring transparency across the entire supply chain, from manufacturers, to wholesalers, pharmacies, PBMs and health plans.

In 1980, prescription drug spending totaled $12 billion, which was less than five percent of U.S. national health expenditures. Forty years later, prescription drugs are projected to account for nearly $360 billion, about nine percent of total national health expenditures. How does the complex pricing and distribution system work?  What can state governments do to control prescription drug costs? Learn more in our latest issue brief, which looks at the expanding set of policy levers states can access to control the costs of prescription drugs.

Virtual Event – Prescriptions for Change: Navigating the Complex System of Drug Prices

How does the maze of retail prescription drug pricing and distribution work in the United States? What are the implications for consumers and payers attempting to navigate it? On Sept. 17, 2020, KHI held a virtual event to explore the issues in the brief and help shed light on the complex system and the options state policymakers across the country are using to rein in costs.

Access this publication in the Documents & Downloads section.

A recording of the convening is below.

 


About Kansas Health Institute

The Kansas Health Institute supports effective policymaking through nonpartisan research, education and engagement. KHI believes evidence-based information, objective analysis and civil dialogue enable policy leaders to be champions for a healthier Kansas. Established in 1995 with a multiyear grant from the Kansas Health Foundation, KHI is a nonprofit, nonpartisan educational organization based in Topeka.

Learn More About KHI